Therapeutic potential of antisense oligodeoxynucleotides in downregulating p53 oncogenic mutations in cancers.
mutation of the p53 gene is the most common genetic alteration in human cancers. Our study proposes to rationally design a p53 antisense oligonucleotide (ASO) repository, which contains a series of ASOs containing single nucleotide differences to discriminate between each mutant and wild type (WT) p53. The Sfold software was used to predict target-accessibility and we designed an initial series of antisense oligonucleotides (ASO) that target the p53 mutants A161T, R175H and R249S. Western-blot analysis indicated that ASOs strongly inhibited the expression of p53 mutants in a panel of human tumor cell lines (SNU-449, SK-BR-3 and PLC/PRF/5) while having little effect on the expression of WT p53 (HepG2 cells). In three cancer lines harboring each of the p53 mutations, mutant-specific ASO treatment led to a dose-dependent inhibition of cell growth, cell viability, colony formation and invasion, and expression of mutant p53-dependent survival proteins. Our preliminary results indicate that a single nucleotide difference in ASOs can discriminate between mutant and WT p53. These observations support the hypothesis that a p53 ASO repository can be a potentially valuable tool to knock down oncogenic mutant p53 and warrant the testing of a p53 ASO repository in in vivo settings.
Xie
Zhigang
Z
Cancer Science Institute of Singapore, National University of Singapore, Singapore 117456, Singapore.
Chng
Wee Joo
WJ
Tay
Kian Ghee
KG
Liu
Shaw Cheng
SC
Zhou
Jianbiao
J
Chen
Chien-Shing
CS
D000970:Antineoplastic Agents / Q000378:metabolism*; D045744:Cell Line, Tumor; D006801:Humans; D050505:Mutant Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D020125:Mutation, Missense; D020319:Oligodeoxyribonucleotides, Antisense / Q000235:genetics / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
D000970:Antineoplastic Agents; D050505:Mutant Proteins; D020319:Oligodeoxyribonucleotides, Antisense; D016159:Tumor Suppressor Protein p53